Center for Clinical Metabolic Research, Gentofte Hospital, University of Copenhagen, Hellerup, Denmark
Search for other papers by Christine Rode Andreasen in
Google Scholar
PubMed
Center for Clinical Metabolic Research, Gentofte Hospital, University of Copenhagen, Hellerup, Denmark
Search for other papers by Andreas Andersen in
Google Scholar
PubMed
Center for Clinical Metabolic Research, Gentofte Hospital, University of Copenhagen, Hellerup, Denmark
Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Filip Krag Knop in
Google Scholar
PubMed
Center for Clinical Metabolic Research, Gentofte Hospital, University of Copenhagen, Hellerup, Denmark
Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Tina Vilsbøll in
Google Scholar
PubMed
significantly reduced body weight without increasing hypoglycaemia or ketoacidosis ( 60 ). Thus, no convincing data support the general use of GLP-1RAs as adjuvant therapy in patients with T1D. Still, with the right combination and timing with insulin, treatment
University of Belgrade, Medical Faculty, Belgrade, Serbia
Search for other papers by Marko Stojanovic in
Google Scholar
PubMed
Search for other papers by Zida Wu in
Google Scholar
PubMed
Search for other papers by Craig E Stiles in
Google Scholar
PubMed
University of Belgrade, Medical Faculty, Belgrade, Serbia
Search for other papers by Dragana Miljic in
Google Scholar
PubMed
Insitute of Medical Statistics and Informatics, Belgrade, Serbia
Search for other papers by Ivan Soldatovic in
Google Scholar
PubMed
University of Belgrade, Medical Faculty, Belgrade, Serbia
Search for other papers by Sandra Pekic in
Google Scholar
PubMed
University of Belgrade, Medical Faculty, Belgrade, Serbia
Search for other papers by Mirjana Doknic in
Google Scholar
PubMed
University of Belgrade, Medical Faculty, Belgrade, Serbia
Search for other papers by Milan Petakov in
Google Scholar
PubMed
Search for other papers by Vera Popovic in
Google Scholar
PubMed
Search for other papers by Christian Strasburger in
Google Scholar
PubMed
Search for other papers by Márta Korbonits in
Google Scholar
PubMed
0.1 ng/mL range. Baseline serum AIP was independent of age, gender or BMI. Serum AIP levels in all investigated groups were stable over time in samples taken at 30-min intervals over 2-h course and were unchanged by severe hypoglycaemia (induced by
Search for other papers by Aldo Bonaventura in
Google Scholar
PubMed
Department of Internal Medicine, Division of Cardiology, Division of Laboratory Medicine, First Clinic of Internal Medicine, University of Genoa School of Medicine, IRCCS Azienda Ospedaliera Universitaria San Martino – IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy
Department of Internal Medicine, Division of Cardiology, Division of Laboratory Medicine, First Clinic of Internal Medicine, University of Genoa School of Medicine, IRCCS Azienda Ospedaliera Universitaria San Martino – IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy
Search for other papers by Fabrizio Montecucco in
Google Scholar
PubMed
Search for other papers by Franco Dallegri in
Google Scholar
PubMed
measures recommended to limit iatrogenic hypoglycaemia are summarized in Fig. 1 . Figure 1 Measures to limit iatrogenic hypoglycemia. The first step is to limit the hypoglycemic episodes, since this approach can completely restore hypoglycemia awareness in
Search for other papers by Sommayya Aftab in
Google Scholar
PubMed
Search for other papers by Diliara Gubaeva in
Google Scholar
PubMed
Search for other papers by Jayne A L Houghton in
Google Scholar
PubMed
Search for other papers by Antonia Dastamani in
Google Scholar
PubMed
Search for other papers by Ellada Sotiridou in
Google Scholar
PubMed
Search for other papers by Clare Gilbert in
Google Scholar
PubMed
Search for other papers by Sarah E Flanagan in
Google Scholar
PubMed
Search for other papers by Anatoly Tiulpakov in
Google Scholar
PubMed
Search for other papers by Maria Melikyan in
Google Scholar
PubMed
Search for other papers by Pratik Shah in
Google Scholar
PubMed
’-triphosphate (GTP) ( 5 , 6 ). Activated mutations in the GLUD1 gene lead to loss of this allosteric inhibition by GTP, which in turn increases leucine-induced glutamate oxidation to alpha-ketoglutarate, resulting in hyperinsulinemic hypoglycaemia ( 7 ). This
Faculty of Medicine, University of Oslo, Oslo, Norway
Search for other papers by Espen Nordheim in
Google Scholar
PubMed
Search for other papers by Jørn Petter Lindahl in
Google Scholar
PubMed
Search for other papers by Rasmus Kirkeskov Carlsen in
Google Scholar
PubMed
Department of Pharmacy, University of Oslo, Oslo, Norway
Search for other papers by Anders Åsberg in
Google Scholar
PubMed
Faculty of Medicine, University of Oslo, Oslo, Norway
Search for other papers by Kåre Inge Birkeland in
Google Scholar
PubMed
Search for other papers by Rune Horneland in
Google Scholar
PubMed
Department of Behavioural Medicine, University of Oslo, Oslo, Norway
Search for other papers by Birgitte Boye in
Google Scholar
PubMed
Centre of Excellence-HTH, Institute of Basic Medical Sciences, University of Oslo, Oslo, Norway
Search for other papers by Hanne Scholz in
Google Scholar
PubMed
Faculty of Medicine, University of Oslo, Oslo, Norway
Metabolic and Renal Research Group, Faculty of Health Sciences, UiT-The Arctic University of Norway, Tromsø, Norway
Search for other papers by Trond Geir Jenssen in
Google Scholar
PubMed
1 diabetes. Patients with different phenotypes of diabetes have been accepted, the major categories being patients with persistent hyperglycaemia (HbA1c > 10% (>86 mmol/mol)), patients with recurring episodes of hypoglycaemia or with fluctuating or
Institute of Clinical Medicine, University of Oslo, Oslo, Norway
Department of Clinical Molecular Biology, University of Oslo and Akershus University Hospital, Lørenskog, Norway
Search for other papers by Ivar Følling in
Google Scholar
PubMed
Search for other papers by Anna B Wennerstrøm in
Google Scholar
PubMed
Search for other papers by Tor J Eide in
Google Scholar
PubMed
Department of Clinical Molecular Biology, University of Oslo and Akershus University Hospital, Lørenskog, Norway
Search for other papers by Hilde Loge Nilsen in
Google Scholar
PubMed
/or cure of hypoglycaemia after tumour extirpation ( 10 , 12 , 13 ). There are also reports of patients with hyperinsulinemic hypoglycaemia without convincing evidence that their extrapancreatic tumour produced the insulin. Dysregulated ectopic
Search for other papers by Rama Lakshman in
Google Scholar
PubMed
Cambridge University Hospitals NHS Foundation Trust, Wolfson Diabetes and Endocrine Clinic, Cambridge, UK
Search for other papers by Charlotte Boughton in
Google Scholar
PubMed
Search for other papers by Roman Hovorka in
Google Scholar
PubMed
microvascular complications ( 2 ). Optimal glycaemic control is often limited by the risk of hypoglycaemia, and is made more challenging because insulin needs vary considerably day to day ( 3 ). A minority of people with T1D currently achieve the recommended
Department of Research and Development, Region Kronoberg, Växjö, Sweden
Search for other papers by Eva Olga Melin in
Google Scholar
PubMed
Search for other papers by Magnus Hillman in
Google Scholar
PubMed
Department of Endocrinology, Skane University Hospital, Lund, Sweden
Search for other papers by Mona Landin-Olsson in
Google Scholar
PubMed
control, hypoinsulinaemia, hypoglycaemia episodes, impaired kidney function, depression, physical inactivity, smoking and other types of substance abuse, all affect the levels of cortisol secretion ( 21 , 22 , 23 , 24 , 25 , 26 , 27 , 28 ). In our
Search for other papers by Louise Færch in
Google Scholar
PubMed
Department of Cardiology, Department of Growth and Reproduction, Faculty of Health Sciences, Nephrology and Endocrinology H, Hillerød University Hospital, Dyrehavevej 29, DK-3400 Hillerød, Denmark
Search for other papers by Anders Juul in
Google Scholar
PubMed
Search for other papers by Ulrik Pedersen-Bjergaard in
Google Scholar
PubMed
Department of Cardiology, Department of Growth and Reproduction, Faculty of Health Sciences, Nephrology and Endocrinology H, Hillerød University Hospital, Dyrehavevej 29, DK-3400 Hillerød, Denmark
Search for other papers by Birger Thorsteinsson in
Google Scholar
PubMed
P Mathiesen ER . Lower levels of circulating IGF-I in type 1 diabetic women with frequent severe hypoglycaemia during pregnancy . Diabetic Medicine 2008 25 826 – 833 . ( doi:10.1111/j.1464-5491.2008.02495.x ). 6 Tan K Baxter RC . Serum
Centre for Endocrinology, Diabetes and Metabolism, Birmingham Health Partners, Birmingham, UK
Search for other papers by Wiebke Arlt in
Google Scholar
PubMed
Search for other papers by the Society for Endocrinology Clinical Committee in
Google Scholar
PubMed
Hypoglycaemia (primarily in affected children; can cause long-term neurological deficits, if not promptly treated) Investigations for suspected adrenal crisis in patients not already known to have adrenal failure Adrenal insufficiency should be ruled